Startup based in the United States, 3 tracked investors.
Based in the United States, Dren Bio is a startup founded in 2019. Brouky records 3 investors associated with the company.
Dren Bio is a clinical-stage biopharmaceutical company developing novel antibody therapeutics that selectively target and deplete pathogenic cells for the treatment of cancer and autoimmune diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.